|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets: | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Deferred offering costs | |||||
| Total Current Assets | |||||
| Investments held in trust account | |||||
| Total Assets | |||||
| Liabilities, Temporary Equity and Shareholders' Deficit | |||||
| Current liabilities: | |||||
| Amount due to related parties | |||||
| Promissory note-related parties | |||||
| Accrued expenses | |||||
| Total Current Liabilities | |||||
| Deferred underwriting fee payable | |||||
| Total Liabilities | |||||
| Accrued offering costs | |||||
| Ordinary shares subject to possible redemption, $0.0001 par value; 495,000,000 shares authorized; 6,900,000 shares at redemption value of $10.52 and $10.12 per share as of September 30, 2024 and December 31, 2023, respectively | |||||
| Shareholder's Deficit | |||||
| Ordinary shares, $0.0001 par value, 495,000,000 shares authorized; 2,075,000 shares (excluding 6,900,000 shares, subject to possible redemption) issued and outstanding as of September 30, 2024 and December 31, 2023 | |||||
| Share subscription receivable | |||||
| Accumulated deficit | |||||
| Total Shareholder's Deficit | |||||
| Total Liabilities, Temporary Equity, and Shareholders' Deficit |
Loading...
